{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:04:57Z","timestamp":1791302697410,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1136\/annrheumdis-2012-201517","type":"journal-article","created":{"date-parts":[[2012,7,14]],"date-time":"2012-07-14T06:06:25Z","timestamp":1342245985000},"page":"875-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity"],"prefix":"10.1016","volume":"72","author":[{"given":"Daniel","family":"Aletaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Alasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef S","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2012-201517_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1699-0463.1940.tb01475.x","article-title":"On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles","volume":"17","author":"Waaler","year":"1939","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.1136\/annrheumdis-2012-201517_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/1529-0131(195902)2:1<16::AID-ART1780020104>3.0.CO;2-9","article-title":"Revision of diagnostic criteria for rheumatoid arthritis","volume":"2","author":"Ropes","year":"1958","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib4","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201517_bib5","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard.45.11.945","article-title":"Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy","volume":"45","author":"Dawes","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201517_bib7","first-page":"1070","article-title":"The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis\u2014no relationship with erosions or disease activity","volume":"15","author":"Eberhardt","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201517_bib8","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/rheumatology\/34.12.1146","article-title":"Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis","volume":"34","author":"Paimela","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201517_bib9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2009.122739","article-title":"Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis","volume":"69","author":"Miriovsky","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201517_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/rheumatology\/31.8.519","article-title":"Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients","volume":"31","author":"Van der Heijde","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1136\/annrheumdis-2012-201517_bib11","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/art.1780381013","article-title":"Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis","volume":"38","author":"van der Heide","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.2003.019992","article-title":"Prognostic laboratory markers of joint damage in rheumatoid arthritis","volume":"64","author":"Lindqvist","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201517_bib13","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","article-title":"Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized controlled trial","volume":"50","author":"St Clair","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"Breedveld","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","article-title":"A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis","volume":"343","author":"Bathon","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2012-201517_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2012-201517_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2012-201517_bib18","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/ar1740","article-title":"Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score","volume":"7","author":"Aletaha","year":"2005","journal-title":"Arthritis Res"},{"key":"10.1136\/annrheumdis-2012-201517_bib19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","article-title":"Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score","volume":"49","author":"van der Heijde","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201517_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/art.10181","article-title":"How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion","volume":"47","author":"van der Heijde","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/rheumatology\/kep155","article-title":"A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis","volume":"48","author":"Vastesaeger","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2012-201517_bib22","volume":"Vol 1","author":"Tutorials in Biostatistics","year":"2004"},{"key":"10.1136\/annrheumdis-2012-201517_bib23","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.24433","article-title":"Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment","volume":"60","author":"Aletaha","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib24","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(87)91672-2","article-title":"Long-term outcome of treating rheumatoid arthritis: results after 20\u2005years","volume":"1","author":"Scott","year":"1987","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2012-201517_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/art.1780180603","article-title":"Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues","volume":"18","author":"Cooke","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/art.1780170315","article-title":"Rheumatoid synovitis. An extravascular immune complex disease","volume":"17","author":"Zvaifler","year":"1974","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.10183","article-title":"Local production of complement proteins in rheumatoid arthritis synovium","volume":"46","author":"Neumann","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/art.1780280302","article-title":"Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis","volume":"28","author":"Jasin","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.32.6.557","article-title":"Complement metabolism in rheumatoid arthritis","volume":"32","author":"Versey","year":"1973","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201517_bib30","first-page":"297","article-title":"Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis","volume":"39","author":"Male","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/annrheumdis-2012-201517_bib31","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.141.4.1197","article-title":"Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes","volume":"141","author":"Debets","year":"1988","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201517_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.autrev.2011.05.001","article-title":"Therapeutic blockade of TNF in patients with SLE\u2014promising or crazy?","volume":"11","author":"Aringer","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1136\/annrheumdis-2012-201517_bib33","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/ar1926","article-title":"Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells","volume":"8","author":"Mathsson","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2012-201517_bib34","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/ard.2010.142091","article-title":"Fcgamma receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins","volume":"70","author":"Laurent","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201517_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000060522","article-title":"The role of TNF alpha and IL-1 in rheumatoid arthritis","volume":"3","author":"Feldmann","year":"2001","journal-title":"Curr Dir Autoimmun"},{"key":"10.1136\/annrheumdis-2012-201517_bib36","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm939","article-title":"Lasker clinical medical research award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases","volume":"9","author":"Feldmann","year":"2003","journal-title":"Nat Med"},{"key":"10.1136\/annrheumdis-2012-201517_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.155.1.1","article-title":"Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis","volume":"155","author":"Stuart","year":"1982","journal-title":"J Exp Med"},{"key":"10.1136\/annrheumdis-2012-201517_bib38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/ni772","article-title":"How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint- specific autoimmune disease","volume":"3","author":"Matsumoto","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1136\/annrheumdis-2012-201517_bib39","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.4049\/jimmunol.175.12.8327","article-title":"Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice","volume":"175","author":"Hayer","year":"2005","journal-title":"J Immunol"},{"key":"10.1136\/annrheumdis-2012-201517_bib40","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.200611083","article-title":"Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption","volume":"176","author":"Zou","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1136\/annrheumdis-2012-201517_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrd3669","article-title":"Inflammatory bone loss: pathogenesis and therapeutic intervention","volume":"11","author":"Redlich","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1136\/annrheumdis-2012-201517_bib42","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"10.1136\/annrheumdis-2012-201517_bib43","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"key":"10.1136\/annrheumdis-2012-201517_bib44","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/art.1780330816","article-title":"Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression","volume":"33","author":"Alarcon","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2012-201517_bib45","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201517_bib46","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/ar2995","article-title":"The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis","volume":"12","author":"Mjaavatten","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2012-201517_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard.2006.068247","article-title":"High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study","volume":"67","author":"Syversen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2012-201517_bib48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2012-201517_bib49","series-title":"Rheumatoid arthritis: national clinical guideline for management and treatment in adults","author":"National Collaborating Centre for Chronic Conditions","year":"2009"},{"key":"10.1136\/annrheumdis-2012-201517_bib50","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724214710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724214710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2012-201517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:45:16Z","timestamp":1737351916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724214710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0003496724214710"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201517","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2012-201517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 \u00a9 2013 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}